Influenza vaccine for healthy adults?

New England Journal of Medicine

Volumn 333, Issue 14, 1995, Pages 933-934

  Patriarca, Peter A ^a   Strikas, Raymond A ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG INDICATION; EDITORIAL; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; PRIORITY JOURNAL;

ADULT; COST-BENEFIT ANALYSIS; HUMAN; INFLUENZA; INFLUENZA VACCINE;

EID: 0029135353     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199510053331410     Document Type: Editorial

References (14)

1. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1995; 44: 1-22
2. Barker WH Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health 1986; 76: 761-765
3. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 1988; 108: 616-625
4. Office of Technology Assessment. Cost effectiveness of influenza vaccination. Washington, D.C.: Government Printing Office, 1981. (Library of Congress Catalog Card No. 81-600183.)
5. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-784
6. Mullooly JP, Bennett MD, Hornbrook MC, Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121: 947-952
7. Nichol KL, Lind A, Margolis KL, The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333: 889-893
8. Orenstein WA, Bernier RH, Hinman AR Assessing vaccine efficacy in the field: further observations. Epidemiol Rev 1988; 10: 212-241
9. Dowdle WR. Influenza immunoprophylaxis after 30 years experience. In: Nayak DP, ed. Genetic variation among influenza viruses. New York: Academic Press, 1981:525-34.
10. Sullivan KM, Monto AS, Longini IM Jr Estimates of the US health impact of influenza. Am J Public Health 1993; 83: 1712-1716
11. Glezen WP, Couch RB. Influenza viruses. In: Evans AS, ed. Viral infections of humans: epidemiology and control. 3rd ed. New York: Plenum, 1989:419-49.
12. Noble GR. Epidemiological and clinical aspects of influenza. In: Beere AS, ed. Basic and applied influenza research. Boca Raton, Fla.: CRC Press, 1982:11-50.
13. Influenza and pneumococcal vaccination coverage levels among persons aged ≥65 years -- United States, 1973-1993. MMWR Morb Mortal Wkly Rep 1995; 44: 506-7, 513
14. Schoenbaum SC Economic impact of influenza: the individual's perspective. Am J Med 1987; 82: Suppl 6A: 26-30